CAMPAGNA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 4.256
AS - Asia 2.391
EU - Europa 2.044
SA - Sud America 361
AF - Africa 146
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.220
Nazione #
US - Stati Uniti d'America 4.156
SG - Singapore 839
IT - Italia 613
CN - Cina 489
VN - Vietnam 453
HK - Hong Kong 314
RU - Federazione Russa 308
BR - Brasile 285
FI - Finlandia 168
FR - Francia 147
DE - Germania 146
IE - Irlanda 142
SE - Svezia 110
GB - Regno Unito 88
UA - Ucraina 83
CI - Costa d'Avorio 76
NL - Olanda 75
IN - India 59
AT - Austria 57
CA - Canada 42
TR - Turchia 35
MX - Messico 34
AR - Argentina 31
BD - Bangladesh 30
ZA - Sudafrica 28
JP - Giappone 23
KR - Corea 22
DK - Danimarca 20
AU - Australia 19
ID - Indonesia 19
MA - Marocco 19
PL - Polonia 19
ES - Italia 16
PH - Filippine 16
IQ - Iraq 14
RO - Romania 14
CL - Cile 10
UZ - Uzbekistan 10
PK - Pakistan 9
TH - Thailandia 9
VE - Venezuela 9
BE - Belgio 7
CR - Costa Rica 7
EC - Ecuador 7
LT - Lituania 7
SA - Arabia Saudita 7
TW - Taiwan 7
EG - Egitto 6
KE - Kenya 6
PY - Paraguay 6
CO - Colombia 5
HN - Honduras 5
JO - Giordania 5
CZ - Repubblica Ceca 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
PE - Perù 4
SM - San Marino 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.219
Città #
Dallas 733
Ashburn 702
Singapore 515
Hong Kong 302
Chandler 276
San Jose 270
Des Moines 146
Council Bluffs 145
Dublin 142
Ho Chi Minh City 140
Boardman 136
Helsinki 129
Beijing 106
Fairfield 101
Los Angeles 97
The Dalles 96
Hanoi 93
Ancona 90
New York 88
Jacksonville 85
Abidjan 76
Lauterbourg 68
Seattle 60
Munich 59
Milan 55
Wilmington 52
Moscow 51
Houston 49
Turin 49
Hefei 39
Woodbridge 38
Vienna 37
Lawrence 35
Princeton 35
Cambridge 34
Orem 34
Da Nang 33
Centro 32
Recanati 31
Turku 31
Ann Arbor 28
Chicago 28
Buffalo 26
Shanghai 26
Amsterdam 25
Rome 25
São Paulo 25
Tolentino 25
Nuremberg 24
San Mateo 23
Washington 22
Haiphong 21
San Diego 20
Chennai 19
London 19
Redmond 18
Santa Clara 18
Aversa 16
Pavia 15
Johannesburg 14
Montreal 14
Stockholm 14
Tokyo 14
Brooklyn 13
Istanbul 13
Wuhan 13
Brasov 12
Poplar 12
Atlanta 11
Curitiba 11
Denver 11
Frankfurt am Main 11
Guangzhou 11
Manchester 11
Mexico City 11
Naples 11
Warsaw 11
Boston 10
Hangzhou 10
Marche 10
Ankara 9
Hải Dương 9
Pune 9
Rieti 9
Salt Lake City 9
San Francisco 9
Tashkent 9
New Delhi 8
Paris 8
Baghdad 7
Belo Horizonte 7
Boydton 7
Brussels 7
Casablanca 7
Jakarta 7
Mumbai 7
Phoenix 7
Pittsburgh 7
Biên Hòa 6
Bến Tre 6
Totale 6.115
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 320
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 214
Nicotinamide N-Methyltransferase Inhibition in Endothelium: Effect on Cell Viability and Respiration 213
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 196
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 189
Clinical performance and utility of a NNMT-based urine test for bladder cancer 180
C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells 174
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 173
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 168
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 163
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 161
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 157
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 154
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 153
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 149
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 148
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 147
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 142
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 140
Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury 140
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 136
Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 135
Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium 135
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 133
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 131
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 130
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 128
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 125
Paraoxonase-2 expression in oral squamous cell carcinoma 125
Molecular analysis of endometrial inflammation in preterm birth 124
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 123
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 123
Actin-spectrin scaffold supports open fenestrae in liver sinusoidal endothelial cells 123
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 121
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 116
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 115
Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity 114
PON2 silencing to evaluate the effectiveness of Cisplatin treatment in OSCC cells by FTIRM analyses 114
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 113
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 113
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT) 112
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 111
In Vitro Study of the Proliferation of MG63 Cells Cultured on Five Different Titanium Surfaces 111
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 111
Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics 109
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 108
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 108
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 108
Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 107
Nicotinamide N-methyltransferase gene silencing in endothelial cell lines: molecular and phenotypic characterization 107
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health 105
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside 105
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 104
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 103
Nicotinamide N-methyltransferase inhibition in endothelial cell lines: effect on the cellular phenotype, cell viability and bioenergetic balance 101
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 95
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 93
Effect of nicotinamide N-methyltransferase gene silencing on endothelial bioenergetics. 93
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 92
The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update 90
Nicotinamide N-methyltransferase inhibition in endothelium: effect on the cellular phenotype, viability and bio-energetics 89
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus 88
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 87
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 86
Urinary Cell-Free DNA as a potential diagnostic biomarker for bladder cancer in older adults 85
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response 84
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges 83
Exploring the role of paraoxonase-2 in human clear cell renal cell carcinoma: in vitro effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 80
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 80
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment 80
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 79
Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies 77
Validation of a nomogram for prognosis and stratification of patients with oral carcinoma 73
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 65
Catechol-O-methyltransferase, a potential biomarker for non-invasive diagnosis of human urothelial carcinoma 56
NNMT expression in preeclampsia: Analyses on placental tissues and cell lines 45
Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology 38
Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy 33
Genetic and Epigenetic Biomarkers for the Early Oral Cancerization Risk in Periodontitis Patients 27
Evaluation of nicotinamide N-methyltransferase enzyme expression in preeclampsia: analyses carried out in tissues and cell lines 13
Short and Long Non-Coding RNAs in Renal Cell Carcinoma 11
Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway 3
Totale 9.513
Categoria #
all - tutte 38.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022359 17 59 40 4 0 19 12 59 9 14 45 81
2022/2023921 55 87 63 81 54 214 13 58 182 7 73 34
2023/2024771 98 16 57 66 105 113 10 18 15 95 36 142
2024/20251.552 155 74 78 38 72 32 134 69 249 160 192 299
2025/20265.240 427 293 793 429 564 329 929 416 449 427 168 16
Totale 9.513